Adam Raymakers

Budget Impact Analysis of Gene Therapies for Recessive Dystrophic Epidermolysis Bullosa

This economic evaluation investigated the budget impact associated with gene therapy treatment of autosomal recessive dystrophic epidermolysis bullosa.